~ Mechanisms of Omega-3 Fatty Acid-Induced Growth Inhibition Analyzed

NewsRx.com, 08-18-05

Researchers analyzed the mechanisms of omega-3 fatty acid-induced growth inhibition in MDA-MB-231 human breast cancer cells.

According to a study from Canada, "The omega-3 fatty acids, eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), inhibit the growth of human breast cancer cells in animal models and cell lines, but the mechanism by which this occurs is not well understood. In order to explore possible mechanisms for the modulation of breast cancer cell growth by omega-3 fatty acids, we examined the effects of EPA and DHA on the human breast cancer cell line MDA-MB-231."

"Omega-3 fatty acids (a combination of EPA and DHA) inhibited the growth of MDA-MB-231 cells by 30-40% (p<.05) in both the presence and absence of linoleic acid, an essential omega-6 fatty acid. When provided individually, DHA was more potent than EPA in inhibiting the growth of MDA-MB-231 cells (p<.05)," explained P.D. Schley and colleagues, University of Alberta.

"EPA and DHA treatment decreased tumor cell proliferation (p<.05), as estimated by decreased [methyl-H-3]-thymidine uptake and expression of proliferation-associated proteins (proliferating cell nuclear antigen, PCNA, and proliferation-related kinase, PRK)."

"In addition," continued the investigators, "EPA and DHA induced apoptosis, as indicated by a loss of mitochondrial membrane potential, increased caspase activity and increased DNA fragmentation (p<.05). Cells incubated with omega-3 fatty acids demonstrated decreased Akt phosphorylation, as well as NF kappa B DNA binding activity (p<.05)."

The researchers concluded, "The results of this study indicate that omega-3 fatty acids decrease cell proliferation and induce apoptotic cell death in human breast cancer cells, possibly by decreasing signal transduction through the Akt/NF kappa B cell survival pathway."

Schley and colleagues published their study in Breast Cancer Research and Treatment (Mechanisms of omega-3 fatty acid-induced growth inhibition in MDA-MB-231 human breast cancer cells. Breast Cancer Res Treat, 2005;92(2):187-195).

For more information, contact C.J. Field, University of Alberta, Dept. Agriculture Food & Nutrition Science, 3-18E Agriculture Forestry Center, Edmonton, AB T6G 2P5, Canada.

Publisher contact information for the journal Breast Cancer Research and Treatment is: Springer, 233 Spring Street, New York, NY 10013, USA.

To see more of the NewsRx.com, or to subscribe, go to http://www.newsrx.com.

Free Shipping in the Continental U.S. on Orders over $50
The statements made here have not been evaluated by the FDA. The foregoing statements are based upon sound and reliable studies, and are meant for informational purposes. Consult with your medical practitioner to determine the underlying cause of your symptoms. Please always check your purchase for possible allergins and correct dosage on the bottle before use.

While we work to ensure that product information is correct, on occasion manufacturers may alter their ingredient lists. Actual product packaging and materials may contain more and/or different information than that shown on our Web site. We recommend that you do not solely rely on the information presented and that you always read labels, warnings, and directions before using or consuming a product. For additional information about a product, please contact the manufacturer. Content on this site is for reference purposes and is not intended to substitute for advice given by a physician, pharmacist, or other licensed health-care professional. You should not use this information as self-diagnosis or for treating a health problem or disease. Contact your health-care provider immediately if you suspect that you have a medical problem. Information and statements regarding dietary supplements have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease or health condition. Life Ex Online assumes no liability for inaccuracies or misstatements about products.